Skip to main content

Pharma

By HIMSS TV | 10:45 am | April 15, 2026
AI can streamline workflows across health systems, but Greg O'Neill, ChristianaCare's director of patient education, says the technology misses its purpose if the information it provides to patients and families isn't useful.
By Jessica Hagen | 07:00 am | April 14, 2026
The company's agentic platform works to help pharmaceutical companies turn data into automated analyses, strategic insights and commercialization tools.
By Adam Ang | 09:27 pm | April 05, 2026
Also, 4DMedical has raised $57 million and obtained clearance to expand across Europe.
By Jessica Hagen | 01:41 pm | March 24, 2026
Ellipsis Health partners with PromptWell to boost enrollment in patient care programs, while CaryHealth teams up with HealthDyne to enhance medication management.
By Jessica Hagen | 12:06 pm | March 17, 2026
The pharma giant’s AI factory combines on-premises and cloud GPU infrastructure, leveraging more than 3,500 Blackwell GPUs for AI-driven drug discovery and research.
By Susan Morse | 02:02 pm | February 25, 2026
A strong MFN law could be a meaningful step toward bringing U.S. prices in line with those paid by other high-income countries, says Patients for Affordable Drugs Now.
By Susan Morse | 01:20 pm | February 23, 2026
Physicians tell Dr. Amy Bucher they feel a sense of empowerment in being able to offer patients something that, along with lifestyle changes, reduces weight, lowers the risk of diabetes and high blood pressure, and helps prevent other chronic conditions.
By HIMSS TV | 10:10 am | February 16, 2026
For his upcoming HIMSS26 presentation, ChristianaCare's Greg O'Neill discusses how practical tools like plain language, pictograms, multilingual translation and tailored discharge instructions can boost medication compliance.
By Susan Morse | 01:55 pm | February 12, 2026
Amazon is competing with Walmart in the delivery business and against pharmacies such as CVS and Walgreens.
By Jessica Hagen | 04:33 pm | February 09, 2026
The company will use the funds to advance its brain shuttle platform that delivers RNAi therapies across the blood-brain barrier to help treat neurodegenerative diseases.